Akand, Murat.Kılıç, Özcan.Harmankaya, İsmail.Karabağlı, Pınar.Yavaş, Çağdaş.Ata, Özlem.2020-03-262020-03-262019Akand, M., Kılıç, Ö., Harmankaya, İ., Karabağlı, P., Yavaş, Ç., Ata, Ö. (2019). Aggressive Treatment for Urothelial Cancer-Complete Urinary Tract Extirpation: Operative Feasibility in Two Cases. Turkish Journal of Urology, 45(5), 393-397.2149-32352149-3057https://dx.doi.org/10.5152/tud.2018.55453https://hdl.handle.net/20.500.12395/37460Bladder cancer (BC), the most common malignancy of the urinary tract, accounts for 90-95% of all urothelial carcinomas (UCs), while upper urinary tract UC (UUTUC) accounts for only 5-10%. Radical nephroureterectomy with excision of bladder cuff, and radical cystectomy with pelvic lymph node dissection and a urinary diversion (UD) are the gold standard treatments for UUTUC and muscle-invasive bladder cancer (MIBC), respectively. These two treatments can be performed simultaneously when a bilateral or unilateral UUTUC is present with a MIBC, and are called complete urinary tract extirpation (CUTE) and hemi-CUTE, respectively. This complex surgery can help the patient by avoiding multi-staged surgeries, repeated anesthesia, and delay in completion of treatment. Herein, we report the first cases of a hemi-CUTE and CUTE in our department and share our experience with this aggressive and complex surgical treatment.en10.5152/tud.2018.55453info:eu-repo/semantics/openAccessBladder cancernephroureterectomyradical cystectomyupper urinary tracturinary tract extirpationurothelial carcinomaAggressive treatment for urothelial cancer-complete urinary tract extirpation: operative feasibility in two casesArticle45539339731509514Q3WOS:000484545300013N/A